| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/13/1995 | US5424204 Liquid clinical assay reagent |
| 06/13/1995 | US5424199 Human growth hormone |
| 06/13/1995 | US5424187 Detection of chlamydial markers for diagnosis of infections in coronary arteries |
| 06/13/1995 | US5424185 Human high-affinity neurotransmitter uptake system |
| 06/13/1995 | US5424066 Method for increasing CD4+ cell numbers through the use of monoclonal antibodies directed against self-reactive, CD4 specific cytotoxic T-cells |
| 06/13/1995 | CA1335924C Mixed crystals of insulin and insulin derivatives, a process for the preparation of these mixed crystals, pharmaceutical agents containing these mixed crystals, and the use thereof for the treatment of diabetes mellitus |
| 06/13/1995 | CA1335883C Enhancement of the cellular immune response |
| 06/10/1995 | CA2137206A1 Glucagon-like insulinotropic peptides, compositions and methods |
| 06/09/1995 | CA2136590A1 Recombinant genes expressing pp14 |
| 06/08/1995 | WO1995015396A1 ENTEROTOXINS OF SHIGELLA FLEXNERI 2a |
| 06/08/1995 | WO1995015384A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition |
| 06/08/1995 | WO1995015382A1 Binding structures directed against the ca55.1 antigen |
| 06/08/1995 | WO1995015381A2 HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER |
| 06/08/1995 | WO1995015377A1 Plant arabinogalactan protein (agp) genes |
| 06/08/1995 | WO1995015373A2 Inhibition of dna methyltransferase |
| 06/08/1995 | WO1995015341A1 Antibody against carcinoembryonic antigen (cea) |
| 06/08/1995 | WO1995015340A1 Monoclonal antibodies to antigens expressed by human dendritic cells |
| 06/08/1995 | WO1995015339A1 Antagonists to chaperonin 10 |
| 06/08/1995 | WO1995015338A1 Chaperonin 10 |
| 06/08/1995 | WO1995015336A1 Double-chain hemoregulatory peptides |
| 06/08/1995 | WO1995015308A1 Crystalline, polymorphic form of (s,s,s)-n-(1-[2-carboxy-3-(n2-mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine |
| 06/08/1995 | WO1995015183A1 Hirudin conjugates from hirudin and lipophilic compounds |
| 06/08/1995 | WO1995015181A1 Reperfusion therapy using antibodies to l-selectin |
| 06/08/1995 | WO1995015180A1 Antibodies that mimic actions of neurotrophins |
| 06/08/1995 | WO1995015179A1 Method of treating intestinal disorders |
| 06/08/1995 | WO1995015178A1 Vibrio cholerae bengal serogroup-0139 capsular polysaccharide, protein conjugates thereof and antibodies induced thereby |
| 06/08/1995 | WO1995015177A2 Improved efficacy of alpha-helical cytokines |
| 06/08/1995 | WO1995015176A1 Methods of promoting the survival and differentiation of subclasses of cholinergic and serotonergic neurons using fibroblast growth factor-5 |
| 06/08/1995 | WO1995015175A1 Galectin-8 and galectin-8-like proteins and dna molecules coding therefor |
| 06/08/1995 | WO1995015171A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN |
| 06/08/1995 | WO1995015167A1 In utero gene therapy for fetuses |
| 06/08/1995 | WO1995015151A1 Aerosol drug formulations for use with non-cfc propellants |
| 06/08/1995 | WO1995015084A1 Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof |
| 06/08/1995 | WO1995011912A3 Biopolymer synthesis utilizing surface activated, organic polymers |
| 06/08/1995 | WO1995011309A3 A novel nuclear mitotic phosphoprotein: mitosin |
| 06/08/1995 | WO1995007708A3 Therapeutic use of the retinoblastoma susceptibility gene product |
| 06/08/1995 | WO1995002054A3 Platelet glycoprotein v gene and uses |
| 06/08/1995 | DE4437502A1 Conjugates of hirudin with lipophilic cpds. |
| 06/08/1995 | DE4407484A1 Cancer medicament for parenteral admin. |
| 06/08/1995 | DE4341479A1 Antiviral therapy using metallo:thioneine and apo:thioneine |
| 06/08/1995 | DE4341476A1 Compsn. for studying and modulating cellular changes |
| 06/08/1995 | DE4341471A1 New small peptide(s) that inhibit tumour necrosis factor |
| 06/08/1995 | CA2177998A1 In utero gene therapy for fetuses |
| 06/08/1995 | CA2177991A1 A 46 kd human milk fat globule antigen |
| 06/08/1995 | CA2177953A1 Plant arabinogalactan protein (agp) genes |
| 06/08/1995 | CA2177699A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition |
| 06/08/1995 | CA2177584A1 Antibody against carcinoembryonic antigen (cea) |
| 06/08/1995 | CA2177570A1 Method of treating intestinal disorders |
| 06/08/1995 | CA2177252A1 Human mutator gene hmsh2 and hereditary non polyposis colorectal cancer |
| 06/08/1995 | CA2177031A1 Inhibition of dna methyltransferase |
| 06/08/1995 | CA2176967A1 Hirudin conjugates from hirudin and lipophilic compounds |
| 06/08/1995 | CA2174972A1 Binding structures directed against the ca55.1 antigen |
| 06/07/1995 | EP0656418A1 Superoxide dismutase and expression in microorganisms |
| 06/07/1995 | EP0656367A1 Method and composition for cancer therapy and for prognosticating responses to cancer theraphy |
| 06/07/1995 | EP0656366A1 Iron-lactoferrin combination and process for producing the same |
| 06/07/1995 | EP0656356A1 Dioxacycloalkane compound with renin-inhibiting activity |
| 06/07/1995 | EP0656215A1 Glycosaminoglycan-synthetic polymer conjugates |
| 06/07/1995 | EP0656214A1 Clear, chemically-modified collagensynthetic polymer conjugates for ophthalmic applications |
| 06/07/1995 | EP0656213A1 Treatment of conditions and disease |
| 06/07/1995 | EP0656212A1 Liquid compositions containing cyclosporin and process for their preparation |
| 06/07/1995 | EP0656201A1 Use of stimulators of glutathione synthesis as hait growth promotors |
| 06/07/1995 | EP0656121A1 Method for diagnosing and monitoring sepsis |
| 06/07/1995 | EP0656115A1 Improved detection and therapy of lesions with biotin/avidin conjugates |
| 06/07/1995 | EP0656069A1 Inhibitors of cell proliferation, their preparation and use |
| 06/07/1995 | EP0656067A1 Screening methods for immunosuppressive agents |
| 06/07/1995 | EP0656062A1 Dorsal tissue affecting factor and compositions |
| 06/07/1995 | EP0656061A1 Novel glycoforms of soluble complement receptor 1 |
| 06/07/1995 | EP0656060A1 Androgen regulation with dna sequences of rat probasin gene |
| 06/07/1995 | EP0656014A1 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition |
| 06/07/1995 | EP0656013A1 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
| 06/07/1995 | EP0656012A1 T cell epitopes of ryegrass pollen allergen |
| 06/07/1995 | EP0656011A1 Anti-inflammatory peptide analogs and treatment to inhibit vascular leakage in injured tissues |
| 06/07/1995 | EP0656010A1 New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods |
| 06/07/1995 | EP0656009A1 Glycyl-hystidyle-lysine (ghl) derivatives |
| 06/07/1995 | EP0656008A1 Thrombin receptor antagonists |
| 06/07/1995 | EP0655926A1 New tumor diagnosing or therapeutical probe |
| 06/07/1995 | EP0655925A1 Anti-cancer therapeutic compositions containing whey protein concentrate |
| 06/07/1995 | EP0655924A1 A COMBINATION OF ANTI-erbB-2 MONOCLONAL ANTIBODIES AND METHOD OF USING |
| 06/07/1995 | EP0655888A1 Production of human hemoglobin in transgenic pigs |
| 06/07/1995 | EP0632820A4 High concentration homogenized collagen compositions. |
| 06/07/1995 | EP0603312A4 Novel gaba a? receptor with steroid binding sites. |
| 06/07/1995 | EP0598034A4 Production of peptide amides. |
| 06/07/1995 | EP0462277B1 Glycoprotein of human origin, physiologically active factor comprising the same, and pharmaceutical preparation containing the same as active ingredient |
| 06/07/1995 | EP0454783B1 Site specific in-vivo activation of therapeutic drugs |
| 06/07/1995 | EP0330655B1 Method for introduction of disease and pest resistance into plants and novel genes incorporated into plants which code therefor |
| 06/07/1995 | CN1103533A Biologically active ureido derivatives useful as antimetastatic agents |
| 06/07/1995 | CN1103431A Determination of lymph nodes enriched in tumor reactive... |
| 06/07/1995 | CN1103316A Cyclodextrin and polymer-based drug delivery system |
| 06/07/1995 | CN1103315A Improved methods for the determination and adjustment of prolactin daily rhythms |
| 06/06/1995 | US5422424 Antibiotic cryptdin peptides and methods of their use |
| 06/06/1995 | US5422350 Nitrogen substituted acridine and cytochrome P450 inhibitors and methods of use |
| 06/06/1995 | US5422344 Method of treating retroviral infections in mammals |
| 06/06/1995 | US5422342 A hydrolase inhibitor comprising a protected oligopeptides for treating fibrose of lungs, liver and skins, atherosclerosis |
| 06/06/1995 | US5422341 Motilin-like polypeptides with gastrointestinal motor stimulating activity |
| 06/06/1995 | US5422340 TGF-βformulation for inducing bone growth |
| 06/06/1995 | US5422339 Peptides having insulin autoantibody but not insulin receptor binding capacity |
| 06/06/1995 | US5422274 Internal deletion mutants of soluble T4(CD4) |
| 06/06/1995 | US5422261 Pure, aqueous, nontoxic mixtures of proteolytic enzymes in buffered physiologically compatible electrolyte solutions |
| 06/06/1995 | US5422260 An isolated protein coagulants for blood clotting; genetic engineering, culture product |
| 06/06/1995 | US5422258 Methods for producing high affinity anti-human IgE-monoclonal antibodies which binds to IgE on IgEabearing B cells but not basophils |